Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Michael
Michael is currently pursuing his dermatology residency training at the Harvard Combined Dermatology Residency Training Program in Boston, MA.
John
John is an MD student and 21st Century Scholar at UPenn. He graduated from the University of Virginia with a BA in Politics and History (Phi Beta Kappa), and earned his premed postbacc at Goucher College in Baltimore.